BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
7 results:

  • 1. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
    Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
    Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biosafety and differentially expressed genes analysis of melanoma cells treated with cold atmospheric plasma.
    Zhao L; Yan C; Kong S; Jia T; Chu Z; Yang L; Wu J; Geng S; Guo K
    J Biophotonics; 2022 Jun; 15(6):e202100403. PubMed ID: 35261164
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting non-canonical activation of GLI1 by the SOX2-brd4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma.
    Pietrobono S; Gaudio E; Gagliardi S; Zitani M; Carrassa L; Migliorini F; Petricci E; Manetti F; Makukhin N; Bond AG; Paradise BD; Ciulli A; Fernandez-Zapico ME; Bertoni F; Stecca B
    Oncogene; 2021 Jun; 40(22):3799-3814. PubMed ID: 33958721
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Clinical value of high-resolution dynamic contrast-enhanced (DCE) MRI in diagnosis of cutaneous squamous cell carcinoma.
    Tang M; Huang R; Chen J; Sheng M; Zhang Z; Xing J; Guo L; Li Y
    Skin Res Technol; 2021 Jul; 27(4):511-520. PubMed ID: 33141995
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BET inhibitor suppresses melanoma progression
    Deng G; Zeng F; Su J; Zhao S; Hu R; Zhu W; Hu S; Chen X; Yin M
    Theranostics; 2020; 10(25):11428-11443. PubMed ID: 33052224
    [No Abstract]    [Full Text] [Related]  

  • 6. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).
    Scolyer RA; Judge MJ; Evans A; Frishberg DP; Prieto VG; Thompson JF; Trotter MJ; Walsh MY; Walsh NM; Ellis DW;
    Am J Surg Pathol; 2013 Dec; 37(12):1797-814. PubMed ID: 24061524
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Phosphorylated 4E-BP1 is associated with poor survival in melanoma.
    O'Reilly KE; Warycha M; Davies MA; Rodrik V; Zhou XK; Yee H; Polsky D; Pavlick AC; Rosen N; Bhardwaj N; Mills G; Osman I
    Clin Cancer Res; 2009 Apr; 15(8):2872-8. PubMed ID: 19336517
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.